LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA
Position in JNJ — Johnson & Johnson
CIK 932974
BOSTON, MA
Position in JNJ
as of Jun 30, 2026
· filed Jul 30, 2026
Position Value
$64,197,266
+$1,556,828 QoQ
Shares Held
252,775
-1.4% QoQ
Ownership
0.010%
of shares outstanding
% of Portfolio
0.63%
of 13F equity value
Holder Rank
#393
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 98%
Shared 0%
None 2%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA holds $220,949,345 across 14 Drug Manufacturers - General names. JNJ ranks #2 (29.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
59,780 | $71,701,930 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
252,775 | $64,197,266 | |
| 3 | MRK |
Merck & Co., Inc.
|
332,735 | $42,756,447 | |
| 4 | AMGN |
Amgen Inc
|
50,038 | $18,119,760 | |
| 5 | ABBV |
AbbVie Inc.
|
61,527 | $15,482,654 | |
| 6 | NVS |
Novartis AG
|
11,917 | $1,867,632 | |
| 7 | NVO |
Novo Nordisk A S
|
36,192 | $1,735,044 | |
| 8 | PFE |
Pfizer Inc
|
56,816 | $1,368,129 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $64,197,266 | 252,775 | Shares | Sole | 2026-07-30 | |
| 2026-03-31 | $62,640,438 | 256,261 | Shares | Sole | 2026-04-13 | |
| 2025-12-31 | $54,262,909 | 262,203 | Shares | Sole | 2026-01-28 | |
| 2025-09-30 | $49,359,731 | 266,205 | Shares | Sole | 2025-10-24 | |
| 2025-06-30 | $41,201,867 | 269,734 | Shares | Sole | 2025-07-30 | |
| 2025-03-31 | $45,186,756 | 272,472 | Shares | Sole | 2025-04-24 | |
| 2024-12-31 | $40,657,165 | 281,131 | Shares | Sole | 2025-01-28 | |
| 2024-09-30 | $46,947,970 | 289,695 | Shares | Sole | 2024-10-25 | |
| 2024-06-30 | $43,568,541 | 298,088 | Shares | Sole | 2024-07-17 | |
| 2024-03-31 | $48,610,204 | 307,290 | Shares | Sole | 2024-04-23 | |
| 2023-12-31 | $51,555,233 | 328,922 | Shares | Sole | 2024-02-01 | |
| 2023-09-30 | $53,184,108 | 341,471 | Shares | Sole | 2023-11-03 | |
| 2023-06-30 | $60,713,727 | 366,806 | Shares | Sole | 2023-08-01 | |
| 2023-03-31 | $56,772,470 | 366,274 | Shares | Sole | 2023-05-02 | |
| 2022-12-31 | $63,707,231 | 360,641 | Shares | Sole | 2023-03-02 | |
| 2022-09-30 | $59,049,084 | 361,466 | Shares | Sole | 2022-10-25 | |
| 2022-06-30 | $64,217,791 | 361,770 | Shares | Sole | 2022-07-26 | |
| 2022-03-31 | $64,105,153 | 361,706 | Shares | Sole | 2022-04-13 | |
| 2021-12-31 | $63,606,732 | 371,817 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $60,501,936 | 374,625 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $62,533,821 | 379,591 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $62,407,145 | 379,721 | Shares | Sole | 2021-04-14 | |
| 2020-12-31 | $60,597,122 | 385,037 | Shares | Sole | 2021-01-14 | |
| 2020-09-30 | $57,932,929 | 389,125 | Shares | Sole | 2020-10-15 | |
| 2020-06-30 | $56,060,602 | 398,639 | Shares | Sole | 2020-07-30 | |
| 2020-03-31 | $52,464,718 | 400,097 | Shares | Sole | 2020-04-15 | |
| No filing history on record for this holder in this stock. | ||||||